Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 23% ± 4% | |
endothelial cell | 4 studies | 18% ± 2% | |
GABAergic neuron | 3 studies | 27% ± 6% | |
glutamatergic neuron | 3 studies | 33% ± 6% | |
abnormal cell | 3 studies | 24% ± 5% | |
goblet cell | 3 studies | 27% ± 13% | |
transit amplifying cell | 3 studies | 25% ± 3% | |
astrocyte | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7840.74 | 1445 / 1445 | 100% | 74.69 | 183 / 183 |
breast | 100% | 7909.30 | 459 / 459 | 100% | 58.17 | 1117 / 1118 |
intestine | 100% | 8113.27 | 966 / 966 | 100% | 62.67 | 526 / 527 |
bladder | 100% | 8305.90 | 21 / 21 | 100% | 58.94 | 503 / 504 |
skin | 100% | 10017.71 | 1809 / 1809 | 100% | 63.46 | 471 / 472 |
uterus | 100% | 9251.06 | 170 / 170 | 100% | 54.10 | 458 / 459 |
lung | 100% | 7395.19 | 578 / 578 | 100% | 55.79 | 1152 / 1155 |
pancreas | 100% | 5682.15 | 327 / 328 | 100% | 45.55 | 178 / 178 |
stomach | 100% | 7146.72 | 359 / 359 | 100% | 62.27 | 285 / 286 |
prostate | 100% | 7401.85 | 245 / 245 | 100% | 48.55 | 500 / 502 |
thymus | 100% | 9511.11 | 653 / 653 | 99% | 43.13 | 600 / 605 |
kidney | 100% | 5933.36 | 89 / 89 | 98% | 37.30 | 887 / 901 |
ovary | 100% | 8573.87 | 180 / 180 | 98% | 46.76 | 422 / 430 |
liver | 100% | 4178.36 | 226 / 226 | 97% | 28.24 | 394 / 406 |
brain | 95% | 3658.15 | 2518 / 2642 | 100% | 42.82 | 704 / 705 |
adrenal gland | 100% | 6907.71 | 258 / 258 | 94% | 30.59 | 216 / 230 |
adipose | 100% | 7700.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7063.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 62.89 | 29 / 29 |
muscle | 100% | 11137.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8979.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.02 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 52.04 | 79 / 80 |
heart | 98% | 4348.09 | 842 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 5360.56 | 746 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140469 | Biological process | GCN2-mediated signaling |
GO_0160127 | Biological process | protein-RNA covalent cross-linking repair |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006417 | Biological process | regulation of translation |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0005829 | Cellular component | cytosol |
GO_0005840 | Cellular component | ribosome |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0008135 | Molecular function | translation factor activity, RNA binding |
GO_0019887 | Molecular function | protein kinase regulator activity |
GO_0170011 | Molecular function | stalled ribosome sensor activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | GCN1 |
Protein name | Alternative protein GCN1L1 Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1) |
Synonyms | KIAA0219 GCN1L1 |
Description | FUNCTION: Ribosome collision sensor that plays a key role in the RNF14-RNF25 translation quality control pathway, a pathway that takes place when a ribosome has stalled during translation, and which promotes ubiquitination and degradation of translation factors on stalled ribosomes . Directly binds to the ribosome and acts as a sentinel for colliding ribosomes: activated following ribosome stalling and promotes recruitment of RNF14, which directly ubiquitinates EEF1A1/eEF1A, leading to its degradation . In addition to EEF1A1/eEF1A, the RNF14-RNF25 translation quality control pathway mediates degradation of ETF1/eRF1 and ubiquitination of ribosomal protein . GCN1 also acts as a positive activator of the integrated stress response (ISR) by mediating activation of EIF2AK4/GCN2 in response to amino acid starvation (By similarity). Interaction with EIF2AK4/GCN2 on translating ribosomes stimulates EIF2AK4/GCN2 kinase activity, leading to phosphorylation of eukaryotic translation initiation factor 2 (eIF-2-alpha/EIF2S1) (By similarity). EIF2S1/eIF-2-alpha phosphorylation converts EIF2S1/eIF-2-alpha into a global protein synthesis inhibitor, leading to a global attenuation of cap-dependent translation, and thus to a reduced overall utilization of amino acids, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4, and hence allowing ATF4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion (By similarity). . |
Accessions | L8EAJ9 ENST00000300648.7 Q92616 |